BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0800
+0.0050 (6.67%)
Oct 26, 2026, 2:55 PM AEDT
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 29.49 million as of October 27, 2026. It is the 36,612th most valuable company in the world and the 951st biggest in Australia. Its market cap has decreased by 10.45% in one year.
Market Cap
29.49M
Enterprise Value
34.82M
Revenue
2.35M
Global Rank
Country Rank
#951 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 29.49M, a decrease of -42.97%. That is a compound annual growth rate of -10.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 29.49M | -23.68% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 547.74M |
| Healius | 330.40M |
| Monash IVF Group | 276.64M |
| Identifai Genetics | 64.31M |
| Cryosite | 59.55M |
| Microba Life Sciences | 24.51M |
| Rhythm Biosciences | 23.00M |
| INOVIQ | 19.71M |